494 related articles for article (PubMed ID: 9149)
21. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
Kahn NN; Sinha AK
Biochim Biophys Acta; 1989 Aug; 984(1):113-8. PubMed ID: 2548620
[TBL] [Abstract][Full Text] [Related]
22. Effect of partially purified NSILA on adenylate cyclase, phosphodiesterase and 3',5'-cyclic AMP in fat cells.
Hepp KD; Renner R; Langley J; Häring HU
Mol Cell Endocrinol; 1975 Oct; 3(4):309-21. PubMed ID: 172393
[TBL] [Abstract][Full Text] [Related]
23. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
[No Abstract] [Full Text] [Related]
24. Adenylate cyclase, cyclic nucleotide phosphodiesterase, and norepinephrine binding in rat heart membranes.
Moffet FJ; Kidwai AM; Bär HP
Recent Adv Stud Cardiac Struct Metab; 1976; 9():183-91. PubMed ID: 176694
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
Farndale RW; Winkler AB; Martin BR; Barnes MJ
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
27. Excitation-secretion coupling in exocrine glands. Properties of cyclic AMP phosphodiesterase and adenylate cyclase from the submaxillary gland and pancreas.
Lemon MJ; Bhoola KD
Biochim Biophys Acta; 1975 Mar; 385(1):101-13. PubMed ID: 164921
[TBL] [Abstract][Full Text] [Related]
28. Adenylate cyclase and phosphodiesterase in transitional epithelium of the urinary bladder.
Chlapowski FJ
Life Sci; 1976 Feb; 18(3):351-9. PubMed ID: 176554
[No Abstract] [Full Text] [Related]
29. Characterization of cyclic nucleotide metabolism during human monocyte differentiation.
O'Dorisio MS; Fertel R; Finkler E; Brooks R; Vassalo L
J Leukoc Biol; 1984 Jun; 35(6):617-30. PubMed ID: 6144716
[TBL] [Abstract][Full Text] [Related]
30. [Adenylate and guanylate cylase system function in human hyperplastic adrenals in Itsenko-Cushing disease].
Iudaev NA; Afinogenova SA; Kazeev KN; Zhukova TV; Kolesnikova GS
Probl Endokrinol (Mosk); 1984; 30(2):26-30. PubMed ID: 6144097
[TBL] [Abstract][Full Text] [Related]
31. Interrelationships between Ca2+ and adenylate and guanylate cyclases in the control of platelet secretion and aggregation.
Rodan GA; Feinstein MB
Proc Natl Acad Sci U S A; 1976 Jun; 73(6):1829-33. PubMed ID: 6960
[TBL] [Abstract][Full Text] [Related]
32. Studies on cyclic nucleotides in cancer. I. Adenylate guanylate cyclase and protein kinases in the prostatic sarcoma tissue.
Shima S; Kawashima Y; Hirai M; Kouyama H
Biochim Biophys Acta; 1976 Sep; 444(2):571-8. PubMed ID: 9148
[TBL] [Abstract][Full Text] [Related]
33. Effect of hypophysectomy on cyclic 3',5'-nucleotidemetabolizing enzymes in the rat thyroid gland.
Nagasaka A; Hidaka H; Itoh H; Nakagawa H; Kataoka K; Yamaguchi A; Iwase K; Nakai A; Ohyama T; Aono T
J Endocrinol; 1985 Jun; 105(3):363-9. PubMed ID: 2860196
[TBL] [Abstract][Full Text] [Related]
34. Involvement of guanylate cyclase and phosphodiesterases in the functional heterogeneity of human blood platelet subpopulations.
Opper C; Schrumpf E; Gear AR; Wesemann W
Thromb Res; 1995 Dec; 80(6):461-70. PubMed ID: 8610274
[TBL] [Abstract][Full Text] [Related]
35. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
Hidaka H; Endo T
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
[No Abstract] [Full Text] [Related]
36. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
37. Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.
Droller MJ; Wolfe SM
J Clin Invest; 1972 Dec; 51(12):3094-103. PubMed ID: 4344994
[TBL] [Abstract][Full Text] [Related]
38. Ultracytochemical localizations of adenylate cyclase, guanylate cyclase and cyclic 3',5'-nucleotide phosphodiesterase activity on the trophoblast in the human placenta. Direct histochemical evidence.
Matsubara S; Tamada T; Saito T
Histochemistry; 1987; 87(6):505-9. PubMed ID: 2891656
[TBL] [Abstract][Full Text] [Related]
39. Subcellular localization of muscarinic effects on enzymes of cyclic nucleotide metabolism in cultured corneal epithelial cells of the rabbit.
Colley AM; Cavanagh HD; Law ML
Metab Pediatr Syst Ophthalmol (1985); 1987; 10(2):36-8. PubMed ID: 2908207
[TBL] [Abstract][Full Text] [Related]
40. Mepacrine-induced inhibition of human platelet cyclic-GMP phosphodiesterase.
Yamakado T; Tanaka F; Hidaka H
Biochim Biophys Acta; 1984 Sep; 801(1):111-6. PubMed ID: 6147162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
